GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: AR 12286 | AR-12286
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Verosudil is an investigational Rho kinase inhibitor. 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                    The INN record for verosudil indicates that this is a racemic mixture. We show the chemical structure without stereochemistry to represent the mixture. The (2S)-isomer is represented in PubChem CID 86270580 and the (2R)-isomer is represented in CID 44198631.  | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| No information available. | 
Summary of Clinical Use ![]()  | 
                                                        
| Verosudil is being evaluated in Phase 2 clinical trial for its potential to reduce intraocular pressure in patients diagnosed with ocular hypertension or glaucoma [1]. Click here to link to ClinicalTrials.gov's listing of AR-12286 trials. | 
Mechanism Of Action and Pharmacodynamic Effects ![]()  | 
                                                        
| Non-human primate studies suggest that AR-12286 lowers intraocular pressure primarily by increasing aqueous humor outflow through the trabecular meshwork, as do other Rho kinase inhibitors such as fasudil and Y27632. |